App-Quantinova.ai

Ultraearly Hematoma Growth: Multicenter External Validation of the Adjustment of Intracerebral Hemorrhage Volume by Onset-to-imaging Time

David Rodriguez-Luna - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

A Prediction Model for Sudden Cardiac Death in Patients With Heart Failure and Preserved Ejection Fraction

Thomas Rector - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

Irbesartan

Quality of Life in Adolescents and Young Adults After the Fontan Operation: The Pediatric Heart Network Fontan Follow-Up Study

Victor Zak - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Critical Role of miR-181 Family During Oxidative Stress in Heart

Mark Kohr - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

Beyond LDL Cholesterol: Carriers of the PCSK9 R46L Variant Are Characterized by an Anti-Atherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy

S. Matthijs Boekholdt - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diabetes

N/A

Novel Assay for Detection of LDL Transcytosis Across Coronary Endothelium Reveals an Unexpected Role for SR-B1

Michael G. Sugiyama - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Vasodilation dysfunction

Dex-HEMA

Pulmonary Hypertension in S100A1 KO Mice is Associated With Endothelial Cell Dysfunction and Impaired eNOS Activation Dependent in Part on the Receptor for Advanced Glycation End-Products (RAGE)

Jean-Francois Desjardins - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Vasodilation dysfunction

Acetylcholine

Reduced 30-Day Hospital Readmissions in Systolic Heart Failure Patients With Cardiac Resynchronization Therapy: Evidence From 5 Randomized Controlled Trials

Anne B Curtis - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Adiponectin Limits Monocytic Microparticle-Induced Inflammasome Activation and Endothelial Dysfunction

Fina Lovren - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

ICAM-1

Effects of Long Term Autophagy Inhibition With Chloroquine on the Development and Progression of Experimental Abdominal Aortic Aneurysms

Mark D Wheatcroft - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Angiotensin II

Paracrine Engineering of Human Cardiac Stem Cells to Over-Express Stromal Cell-Derived Factor 1? Enhances Post-Ischemic Cardiac Repair

Nicholas Latham - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

CXCL12

Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis

Hasib Hanif - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Mineralocorticoid Receptor Dysregulation by MicroRNA-135a in Bradycardic Arrhythmogenic Remodeling

Jiening Xiao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Cardiac Denervation Appears Before Becoming Myocardial Tissue Fibrosis in Patients With Cardiac Involvement Sarcoidosis and Active Inflammation Using C-11 Hydroxyephedine PET/CT and Cardiac Magnetic Resonance

Ichizo Tsujino - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Sarcoidosis

N/A

Left Ventricular Contractile Reserve Assessed by Exercise Stress Echocardiogram in Adults With Repaired Tetralogy of Fallot: A Novel Early Marker of Intrinsic Myocardial Disease?

Pier-Anne Gilbert - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Bioprosthetic Valves Have a Higher Longevity in Blood Group a Recipients

Nermine Lila - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Predictors of Cardiovascular and Non-Cardiovascular Death: From the Clinic to the Lab

Bernard R Chaitman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Stable coronary artery disease

BARI

High Mortality in the Fischer Rat Model of Severe Pulmonary Arterial Hypertension Linked to Strain-Specific Deficiency in Right Ventricular Adaptation

Colin Suen - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

SU5416

A Novel Role of Autophagy in the Regulation of Endothelial to Mesenchymal Transition

Fina Lovren - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac fibrosis

N/A

Intensive Glycemic Control in Patients With Acute Coronary Syndrome: Evidence From a Meta-Analysis

Ramez Nairooz - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

N/A

Filters

28841 Abstracts